Acronym VOPSA2.0
Category
Marine Biotechnology
Title Value Omega 3 and Astaxanthin products from SeaAlgae Programme H2020
Instrument (FP6)
Contact Type (FP7)
Strand (Interreg)
NA
Theme (FP7)
Activity Area (FP6)
Regional Area (Interreg)
Action (COST)
NA
Specific Programme (FP7)
NA
Funding source European Coordinator NA Coordinator email NA
Coordinator institution
Neoalgae - Neoalgae Micro Seaweeds Products, SL (Spain)
Institutions involved
NA - Bicosome SL (Spain) ,
Start year 2016 End year 2018 Funding (€) € 1,980,665 Website https://cordis.europa.eu/project/id/738661 Summary Omega-3 is an essential oil required by the body for proper functioning. It protects from cardiovascular diseases and improves the development and functioning of the skin as well nervous and visual system. Astaxanthin is a carotenoid pigment and is one of the most effective antioxidants to support human health. The global demand for Omega-3 and Astaxanthin for human consumption will require large quantities of both products:
260.000 tonnes of Omega-3 and 670 tonnes of Astaxanthin per year. This growing demand comes mainly from health conscious customer segment. This segment is also very interested in buying natural and eco-friendly products. However, their traditional extraction process from marine organisms (mainly fish and krill) is not sustainable: over fishing, high energy, raw materials consumption and a low efficiency. The majority of the marine resources are fully exploited or overexploited. The SME Neoalgae has designed an eco-innovative and sustainable industrial bioprocess for obtaining Omega-3 and Astaxanthin using marine microalgae as a natural source. This system is the answer to the growing demand in Omega-3 and Astaxanthin, especially in nutraceutical, cosmetic and pharmaceutical applications. With the new process, production of
Omega-3 and Astaxanthin will not affect marine resources. Both products will be free of pollutants, without fishy aftertaste and odour free, apt for vegans, and with competitive and stable production costs. After the feasibility of the new products has been proved at a technical and market level, this SME-2 project will scale-up the production of both compounds and will demonstrate their effectiveness through their inclusion in nutraceuticals and in new ecological products for the treatment of 3 skin diseases: acne, atopic skin and aging skin produced by the SME Bicosome.
Both companies will benefit from a dramatic boost in their sales and improve their market positions, as well as internationalising their businesses.
Keywords
Bioprospecting;
Nutraceutical substances;
Land-based aquaculture;
Bioactive compounds;
Technology;
Human health;
Marine Region
76
Not associated to marine areas
0
Marine Region Map
